Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype
- 22 May 2001
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 37 (7), 1808-1812
- https://doi.org/10.1016/s0735-1097(01)01237-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Does angiotensin-converting enzyme polymorphism influence the clinical manifestation and progression of heart failure in patients with dilated cardiomyopathy?The American Journal of Cardiology, 1999
- The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failureJournal of the American College of Cardiology, 1996
- Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathyThe Lancet, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failureJournal of the American College of Cardiology, 1992
- Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial)The American Journal of Cardiology, 1990
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Captopril in heart failure. A double blind controlled trial.Heart, 1984